木瓜直播

Shalmali Pal

Shalmali Pal

Authors >

Shalmali Pal

Shalmali Pal joined 木瓜直播 in 2011 as the weekend editor. Shalmali started her career at the Times-Picayune newspaper in New Orleans, before moving to San Francisco, where she worked at several medical media and education outlets (Biomechanics, Auntminnie.com, Oncology News International). She holds a BA in English literature from the University of California Los Angeles and an MSJ from the Medill School of Journalism at Northwestern University. Shalmali also teaches yoga and indoor cycling.

Connect:

email image

Latest from Shalmali Pal

In Pursuit of the Next Big Thing for Second-Line Treatment in Advanced NSCLC

It's time to move beyond chemoIO, experts say; will an ADC own the future?

Bringing Lung Cancer Care to Patients Where They Live

Oncology outreach to rural areas and what can be done to increase trial inclusivity

An 'Exciting' Time for Small-Cell-Lung Cancer Treatment

Encouraging news about novel therapies including the DLL3-targeting BiTE tarlatamab

Illustration of different complementary medicine techniques such as exercise over a breast with cancer

Complementary Therapies in Breast Cancer: Creating a Safe Space

Patients often seek out non-medical methods to cope with diagnosis, symptoms, and well-being

Illustration of different complementary medicine techniques such as exercise over a breast with cancer

For Your Patients: Complementary Therapies and Breast Cancer Care

Science-based approaches, such as acupuncture and yoga, may ease symptoms and bring peace of mind

Immunotherapy for Stage I-II NSCLC Is Promising but Complex

Could improve long-term outcomes -- as long as more clarifying data come down the pipeline

Managing Lung Cancer in Young Adults: Not a Sprint, But a Marathon

Experts outline the gamut that clinicians must run to keep patients ages <70 on track

Lung Cancer Survivorship: Helping Patients With Advanced Disease Have a Chance to Thrive

Guidance on better support systems, and which subgroups remain underserved

Can Topotecan Keep Its Top Billing as Second-Line SCLC Treatment?

RESILIENT 2 tells "a bit of an old story that's new again" for the agent alone or with a co-star

Illustration of an electrical jolt and exclamation point over images of long term effects over a breast with cancer

The Long View on the Long-Term Impact of Breast Cancer Treatment

A high morbidity burden can negatively impact quality of life and emotional health

1